Mendaera
PrivateLast Round
Series B
Sep 26, 2024
Total Funding Raised
$97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mendaera operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Series B round in September 2024.
Mendaera is a healthcare technology company that develops a handheld robotic platform integrating real-time imaging, artificial intelligence, and connectivity to enhance the precision and consistency of needle-based medical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Industrial Robotics, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mendaera Comparables
Compare Mendaera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Interventional Systems | 83% | |
| Automous | 81% | |
| Obvius Robotics, Inc. | 80% |
For institutional investors. Book with your work email.
Mendaera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2024 | ||||
| Series A | Aug 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mendaera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Threshold Ventures | Series B |
| Parade Ventures | Series A |
| Puma Venture Capital | Series B |
| Allen & Company | Series A |
| Gaingels | Series B |
| Founders Fund | Series A |
| Lux Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 252% MoM, reaching 3.1K.
- May 12, 2026
Launched Focalist, an image-guided intervention platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 2, 2026
Mendaera announces that its Focalist robotic image-guided system, which assists clinicians with needle-based procedures including IV placement and nerve blocks, is available to pair with Butterfly Network’s portable, chip-based ultrasound probe on Oct 2nd '26.
For institutional investors. Book with your work email.
Mendaera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mendaera's valuation, stock price, and market status.
Is Mendaera a public or private company?
Mendaera is a private company.
What is the current stock price of Mendaera?
Mendaera is a private company, so its shares have no public market price. Caplight tracks Mendaera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mendaera worth (valuation)?
Valuation information for Mendaera is not publicly available.
Can I buy Mendaera stock?
Mendaera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mendaera's last funding round?
Mendaera's most recent funding round was Series B on September 26, 2024.
Who are the main investors in Mendaera?
Key investors in Mendaera include Threshold Ventures, Lux Capital.
Will Mendaera IPO soon?
No public IPO plans have been announced for Mendaera.
How can I track Mendaera secondary market activity?
Caplight tracks bids, offers, and trades in Mendaera's shares on secondary markets.